RetinaLyze and Rockmed Vision announce strategic cooperation to expand AI-powered eye screening across the Benelux

RetinaLyze, a leader in AI-driven eye screening and tele-ophthalmology, today announced a strategic cooperation with Rockmed Vision to make accessible, high-quality retinal screening available to more patients and providers across the Benelux (the Netherlands, Belgium, and Luxembourg).

RetinaLyze and EyeVinci Announce Strategic Distribution Partnership in the Dutch Market

RetinaLyze System A/S, a pioneer in artificial intelligence (AI) and telemedicine solutions for eye care, is excited to announce a strategic partnership with Eyevinci B.V, a leading provider of digital healthcare innovation.

Medibrix and RetinaLyze Announce Strategic Cooperation to Enhance Eye Health Services

Medibrix, a leading provider of innovative digital healthcare solutions, and RetinaLyze System A/S, a pioneer in AI-based eye screening technology, are proud to announce a new cooperation aimed at improving access to efficient eye health screening through the Medibrix platform.

RetinaLyze and Bloss Group Announce Strategic Distribution Partnership in the Spanish Market

RetinaLyze System A/S, a leading provider of artificial intelligence and telemedicine solutions for the optometry and healthcare industries, is pleased to announce a strategic distribution partnership with Bloxx Digital Innovation, a Bloss Group company.

RetinaLyze and Romger General Trade & Consulting Announce Strategic Distribution Partnership in Romania

RetinaLyze System A/S, a leading provider of artificial intelligence and telemedicine solutions for optometry and healthcare, is pleased to announce a strategic distribution partnership with Romger General Trade & Consulting S.R.L.

RetinaLyze and Surveye Announce Strategic Distribution Partnership in the Slovak Market

Copenhagen, Denmark and Bratislava, Slovakia – January 28, 2024 – RetinaLyze System A/S, a leading provider of artificial intelligence (AI) and telemedicine solutions for the optometry and healthcare industries, is pleased to announce a new strategic distribution partnership with Surveye s.r.o

Merry Christmas 2024!

A thank you and a status to partners, distributors, customers and friends

RetinaLyze and Medicontur CZ Announce Strategic Distribution Partnership in the Czech Republic

Copenhagen, Denmark and Brno, Czech Republic – 10.12.2024 – RetinaLyze System A/S, a leading provider of artificial intelligence and telemedicine solutions for the optometry and healthcare industries, is pleased to announce a strategic distribution partnership with Medicontur CZ s.r.o.

Reflecting on 2024 at RetinaLyze: A Year of Innovation, Growth, and Impact

As we turn the page on 2024, it’s remarkable to look back on the strides we’ve made at RetinaLyze System A/S.

RetinaLyze System receives ISO 13485:2016 certification

RetinaLyze System’s quality management system has been independently audited to be compliant with ISO 13485:2016.

Prof. Gonzalez de la Rosa presents new groundbreaking performance of the Laguna ONhE/RetinaLyze Glaucoma algorithm

Professor Gonzalez de la Rosa (GR), prime inventor of the Laguna ONhE/RetinaLyze Glaucoma algorithm, was invited to lecture at two recent meetings in Madrid.

2018 – Year in review and our fifth birthday!

2018 was quite a year for RetinaLyze System A/S (Ltd.). We launched the glaucoma-algorithm, gave RetinaLyze a visual overhaul and reached 1 million screenings for Diabetic Retinopathy, AMD and Glaucoma!

RetinaLyze receives funding to detect diseases such as Alzheimer’s using AI

RetinaLyze teams up with two universities to develop the next generation of eye screening algorithms, which may detect new diseases in retinal images, such as Alzheimer’s.

RetinaLyze’ new AI algorithm detects signs of glaucoma using retinal images

A team of researchers have developed an algorithm, which automatically detects abnormalities and changes linked to the eye disease glaucoma. The new algorithm is now offered as a part of the software, RetinaLyze, which provides instant eye screening results for the 3 most frequent diseases causing blindness glaucoma, macular degeneration and diabetic retinopathy.

Looking back at RetinaLyze’s 2017

Wow, 2017 was quite a year for RetinaLyze System A/S. We’ve screened over 150.000 people for Diabetic Retinopathy and AMD, won an award and launched both massive features and a host of enhancements.

RetinaLyze wins award

Aarhus Municipality and CareWare-Next awarded the CareWare-Next prizes, the nationwide competition for welfare technology, on Tuesday November 14th.

RetinaLyze nominated for an award

Eight welfare technologies and aids were nominated in the CareWare-Next competition on Wednesday 11 October.

Terry Cooper joining RetinaLyze

We’re excited to announce that Terry Cooper (former Regional Manager at VOLK optical) will soon be joining us in the important UK market.

Disruptive Innovation Theory

Disruptive innovation theory – what is it actually all about? Disruption has indeed become a buzzword! In such an extent that even our law company is hosting an event with the headline “Digitalization and disruption – from buzzword to business”.

Partnering to combat blindness

This past November, Retinalyze Spain and the Eyes of the World Foundation signed a three-year partnership.

Interested in preventing blindness?

Since we are experiencing an increase in demand caused by an increased focus on retinal screening to detect diabetes related eye diseases, we are looking for distributors worldwide.

Implementation in Profil Optik Denmark

We have just completed the first training workshops over two wonderful days with around 120 highly competent opticians/optometrists from Profil Optik.